Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ventripoint Diagnostics Ltd
(OP:
VPTDF
)
0.1432
-0.0009 (-0.62%)
Streaming Delayed Price
Updated: 2:28 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Ventripoint Diagnostics Ltd
Ventripoint Welcomes Evelina London Children's Hospital as Newest VMS+ User
August 22, 2023
Toronto, Ontario – TheNewswire – August 22, 2023 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) is pleased to announce that Evelina London Children’s Hospital...
Via
TheNewswire.com
Ventripoint to Exhibit at the American College of Cardiology 71st Annual Scientific Session and Expo and Correction to North Equities Corp Grant of Stock Options
April 01, 2022
Toronto, Ontario – TheNewswire – April 1, 2022 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce that it will be exhibiting at the 71st...
Via
TheNewswire.com
Ventripoint Announces Patent Application for Improved Heart Analysis
August 09, 2021
Toronto, Ontario – TheNewswire – August 09, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) has filed an international patent application under the Patent...
Via
TheNewswire.com
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Ventripoint Engages Digital257 for Social Media and Investor Relations Services
July 05, 2021
Toronto, Ontario – TheNewswire – July 5, 2021 - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company "), (TSXV:VPT ) ; (OTC:VPTDF) is pleased to announce that it has engaged Digital257...
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ventripoint Issues Option Grants to Consultants and a Director of the Corporation
July 02, 2021
Toronto, Ontario – TheNewswire – July 2, 2021 - Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”) (TSXV:VPT) (OTC:VPTDF) announces that on July 1, 2021 the Board of Directors...
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ventripoint Announces Sponsorship for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology
May 21, 2021
Ventripoint Also Provides a Financial Update
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ventripoint update on its Financial Status and on Warrant and Option Exercises
May 06, 2021
Toronto, Ontario – TheNewswire – May 6, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to provide this update on its financial status and the...
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
Ventripoint Receives Government Funding to Advance Development of Next Generation of VMS+
May 04, 2021
Toronto, Ontario – TheNewswire – May 4, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is excited to announce that it is receiving advisory services and...
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
Ventripoint Collaborates with GE Healthcare to Bring More Functionality to its Cardiac Ultrasound Devices
April 27, 2021
Toronto, Ontario - The Newswire - April 27, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) announces the Company has entered into a collaboration with GE...
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ventripoint Attends 23rd Annual Canadian Echo Weekend and Grants Stock Options
April 20, 2021
Toronto, Ontario – TheNewswire – April 20, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) attended the 23rd Annual Canadian Echo Weekend – 2021 Digital...
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ventripoint Extends Patent Portfolio with Foundational U.S. Provisional Patent Filing of Heart Motion Tracking Technology
April 19, 2021
Toronto, Ontario - The Newswire - April 19, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) has filed a U.S. provisional patent application for its novel...
Via
TheNewswire.com
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
COVID-19
Intellectual Property
Ventripoint Announces Sponsorship for the 2021 Canadian Society of Echocardiography Weekend Conference
April 15, 2021
Toronto, Ontario – TheNewswire – April 15, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce its sponsorship of the 2021 Canadian...
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ventripoint Diagnostics Begins Publication of Case Studies Showing Meritorious Use of the VMS Heart Analysis System
April 13, 2021
Toronto, Ontario – TheNewswire – April 13, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) has published its first case study of the meritorious use of the...
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.